首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1415655

2024 年瘢痕疙瘩治療全球市場報告

Keloids Treatment Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，瘢痕疙瘩治療市場規模一直強勁成長。將從2023年的39.1億美元成長到2024年的41.4億美元，複合年成長率為5.7%。歷史時期的成長歸因於瘢痕疙瘩的高盛行率、瘢痕疙瘩治療意識的提高、與傷口和傷害相關的病例發生率的增加以及整容手術數量的增加。

瘢痕疙瘩治療市場的成長是由傷口和傷害病例發生率上升所推動的。傷口涉及身體組織的物理損傷或傷害，通常涉及皮膚斷裂，並且可能由多種因素造成，包括事故、外科手術、燒燙傷和外傷事件。越來越多的疤痕報告導致了瘢痕疙瘩的形成，從而增加了對有效治療方案的需求。病例激增也提高了人們對瘢痕疙瘩相關併發症的認知、研究的進步以及醫療專業人員之間合作的加強。例如，根據美國勞工統計局2022年11月發布的資料，報告的傷害案件總數增加了6.3%，從2020年的210萬起增加到2021年的220萬起。此外，工傷率也有所上升，私部門雇主報告稱，到 2021 年，每 100 名全職等效 (FTE) 工人中有 2.3 人受傷，高於 2020 年的 2.2 人。因此，傷口和傷害案例發生率的增加預計將推動瘢痕疙瘩治療市場的成長。

2023年，北美是瘢痕疙瘩治療市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。瘢痕疙瘩治療報告的目標區域是亞太地區、西歐、中歐和東歐、北美、南美和中東/非洲。

全球瘢痕疙瘩治療市場，依治療、表現及預測細分，2018-2023、2023-2028、2033
放射治療
冷凍療法
手術治療
雷射治療
類固醇注射
干擾素
其他
全球瘢痕疙瘩治療市場，依產品類型、表現及預測細分，2018-2023、2023-2028、2033
彈性包裹
噴
軟膏
奶油
油
外用凝膠和凝膠片
其他
全球瘢痕疙瘩治療市場，依給藥途徑細分、表現及預測，2018-2023、2023-2028、2033
口服
胃腸外的
全球瘢痕疙瘩治療市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
醫院
居家照護
皮膚科診所
其他

第 7 章區域與國家分析

全球瘢痕疙瘩治療市場，依地區、績效及預測，2018-2023、2023-2028、2033
全球瘢痕疙瘩治療市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

瘢痕疙瘩治療市場競爭形勢
瘢痕疙瘩治療市場公司概況
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Merck &Co. Inc.
- Novartis AG
- Bristol-Myers Squibb Company

第31章其他重大及創新企業

AstraZeneca plc
GlaxoSmithKline plc.
Eli Lilly and Company
Mylan NV
Galderma SA
Sun Pharmaceutical Industries Ltd.
Molnlycke Health Care AB
Cynosure Inc.
Cutera Inc.
Alliance Pharma plc
Revance Therapeutics Inc
Sensus Healthcare
Strata Skin Sciences
Avita Medical Limited
Pacific World Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r12254

“Keloids Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on keloids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for keloids treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The keloids treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Treatment: Radiation Therapy; Cryo Therapy; Surgical Treatment; Laser Treatment; Steroid Injections; Interferon; Other Treatments
2) By Product Type: Elastic Wraps; Sprays; Ointment; Creams; Oils; Topical Gels And Gel Sheets; Other Products
3) By Route Of Administration: Oral; Parenteral
4) By End User: Hospitals; Homecare; Dermatology Clinics; Other End Users
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.

The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The keloids treatment market size has grown strongly in recent years. It will grow from $3.91 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $4.93 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.

Anticipated growth in the keloid treatment market is driven by the rising incidence of wound and injury cases. Wounds, which entail physical injury or harm to the body's tissues, typically involve breaks in the skin and result from various factors such as accidents, surgical procedures, burns, or traumatic events. The escalation in the number of reported wounds contributes to the formation of keloids, thereby increasing the demand for effective treatment options. This surge in cases also fosters heightened awareness regarding keloid-related complications, stimulates advancements in research, and encourages collaboration among medical professionals. For example, data from the U.S. Bureau of Labor Statistics in November 2022 revealed a 6.3% increase in the total reported injury cases, reaching 2.2 million cases in 2021, compared to 2.1 million cases in 2020. Furthermore, the injury rate rose, with private industry employers reporting 2.3 cases per 100 full-time equivalent (FTE) workers in 2021, up from 2.2 cases in 2020. Therefore, the growing incidence of wound and injury cases is expected to drive the growth of the keloid treatment market.

The Keloid Treatment Market is Anticipated to Grow Due to Increasing Interest in Non-Surgical Aesthetic Procedures. Non-surgical aesthetics, which are non-invasive cosmetic treatments aimed at improving one's appearance without surgery, are becoming increasingly popular. Healthcare providers utilize non-surgical aesthetic techniques such as laser therapy, cryotherapy, and dermal fillers to mitigate the appearance and symptoms of keloid scars, which can include reducing inflammation, redness, and vascularization. For example, statistics from the Aesthetic Society, a US-based organization specializing in plastic and cosmetic surgery, revealed a 44% increase in non-surgical procedures in 2021. Furthermore, the use of combination lasers and dermal fillers in procedures reached 431,485 and 1,857,339, respectively, in 2021, showing a 32% and 4% increase. This growing interest in non-surgical aesthetic treatments is expected to be a driving factor for the keloid treatment market's growth.

The growth of the keloid treatment market during the forecast period is hampered by the restricted treatment options. The effectiveness of keloid treatment is often constrained due to the limited availability of treatment modalities. This limitation is further exacerbated by the high rates of keloid recurrence and potential delays in seeking treatment. For instance, in 2023, according to the Mayo Foundation for Medical Education and Research (MFMER), a non-profit organization, the treatment options for keloids are limited, and surgery alone has a recurrence rate of 45% to 100% when keloids have not responded to other therapies. As a result, the limited treatment options act as a barrier to the growth of the keloid treatment market.

Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.

In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.

Major players in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.

North America was the largest region in the keloids treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

1. Executive Summary

2. Keloids Treatment Market Characteristics

3. Keloids Treatment Market Trends And Strategies

4. Keloids Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Keloids Treatment Market Size and Growth

5.1. Global Keloids Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Keloids Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Keloids Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Keloids Treatment Market Segmentation

6.1. Global Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Radiation Therapy
Cryo Therapy
Surgical Treatment
Laser Treatment
Steroid Injections
Interferon
Other Treatments
6.2. Global Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Elastic Wraps
Sprays
Ointment
Creams
Oils
Topical Gels And Gel Sheets
Other Products
6.3. Global Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
6.4. Global Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Dermatology Clinics
Other End Users

7. Keloids Treatment Market Regional And Country Analysis

7.1. Global Keloids Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Keloids Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Keloids Treatment Market

8.1. Asia-Pacific Keloids Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Keloids Treatment Market

9.1. China Keloids Treatment Market Overview
9.2. China Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Keloids Treatment Market

10.1. India Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Keloids Treatment Market

11.1. Japan Keloids Treatment Market Overview
11.2. Japan Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Keloids Treatment Market

12.1. Australia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Keloids Treatment Market

13.1. Indonesia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Keloids Treatment Market

14.1. South Korea Keloids Treatment Market Overview
14.2. South Korea Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Keloids Treatment Market

15.1. Western Europe Keloids Treatment Market Overview
15.2. Western Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Keloids Treatment Market

16.1. UK Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Keloids Treatment Market

17.1. Germany Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Keloids Treatment Market

18.1. France Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Keloids Treatment Market

19.1. Italy Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Keloids Treatment Market

20.1. Spain Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Keloids Treatment Market

21.1. Eastern Europe Keloids Treatment Market Overview
21.2. Eastern Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Keloids Treatment Market

22.1. Russia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Keloids Treatment Market

23.1. North America Keloids Treatment Market Overview
23.2. North America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Keloids Treatment Market

24.1. USA Keloids Treatment Market Overview
24.2. USA Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Keloids Treatment Market

25.1. Canada Keloids Treatment Market Overview
25.2. Canada Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Keloids Treatment Market

26.1. South America Keloids Treatment Market Overview
26.2. South America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Keloids Treatment Market

27.1. Brazil Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Keloids Treatment Market

28.1. Middle East Keloids Treatment Market Overview
28.2. Middle East Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Keloids Treatment Market

29.1. Africa Keloids Treatment Market Overview
29.2. Africa Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Keloids Treatment Market Competitive Landscape And Company Profiles

30.1. Keloids Treatment Market Competitive Landscape
30.2. Keloids Treatment Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bristol-Myers Squibb Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Keloids Treatment Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. GlaxoSmithKline plc.
31.3. Eli Lilly and Company
31.4. Mylan N.V.
31.5. Galderma S.A.
31.6. Sun Pharmaceutical Industries Ltd.
31.7. Molnlycke Health Care AB
31.8. Cynosure Inc.
31.9. Cutera Inc.
31.10. Alliance Pharma plc
31.11. Revance Therapeutics Inc
31.12. Sensus Healthcare
31.13. Strata Skin Sciences
31.14. Avita Medical Limited
31.15. Pacific World Corporation

32. Global Keloids Treatment Market Competitive Benchmarking

33. Global Keloids Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Keloids Treatment Market

35. Keloids Treatment Market Future Outlook and Potential Analysis

35.1 Keloids Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Keloids Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Keloids Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies